Pfizer Told To Pull Drug From Market Days After Pharma Company Annouces Big Corporate Restructuring
WASHINGTON ? Pfizer has been told by the U.S. Food and Drug Administration to pull its painfiller Bextra off the U.S. market and include the strongest safety warning on another high revenue drug, Celebrex. Sales of the two drugs topped $5.20 billion last year. Pfizer said it disagrees with the FDA's position on Bextra but